Colonial Trust Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-742
Closed -$16.8K 696
2024
Q4
$16.8K Hold
742
﹤0.01% 426
2024
Q3
$15.8K Hold
742
﹤0.01% 475
2024
Q2
$14.2K Hold
742
﹤0.01% 477
2024
Q1
$14.3K Hold
742
﹤0.01% 532
2023
Q4
$15.5K Hold
742
﹤0.01% 451
2023
Q3
$16K Hold
742
﹤0.01% 458
2023
Q2
$17.8K Hold
742
﹤0.01% 453
2023
Q1
$15.8K Hold
742
﹤0.01% 455
2022
Q4
$12.1K Buy
+742
New +$11K ﹤0.01% 483

Other funds holding FMS

Colonial Trust Advisors's FMS Position: Q1 2025 in Review

Colonial Trust Advisors sold out of Fresenius Medical Care (FMS) in Q1 2025, closing a stake of 742 shares — an estimated $16.8K sold.

Colonial Trust Advisors first reported a position in FMS in Q4 2022 and held it in 9 quarters. The position peaked at $17.8K in Q2 2023. 201 funds tracked by Wall St. Rank hold FMS as of Q1 2025.

  • Colonial Trust Advisors reported no remaining Fresenius Medical Care position as of Q1 2025 after selling out during the quarter.
  • Colonial Trust Advisors sold 742 Fresenius Medical Care shares in Q1 2025, an estimated $16.8K.
  • Colonial Trust Advisors first reported a position in Fresenius Medical Care in Q4 2022 and held it in 9 quarters.
  • Colonial Trust Advisors's Fresenius Medical Care position peaked at $17.8K in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2025.

Based on Colonial Trust Advisors's 13F filing for Q1 2025, filed 14 May 2025.